GC and cancer: Gc isoforms of the vitamin D binding protein did not modify the association between circulating vitamin D and cancer risk within the PLCO Trial, either for overall cancer or specific cancer sites such as lung, colorectum, breast and prostate, although an interaction was noted for bladder cancer.